- About Us
- Nano-Social Network
- Nano Consulting
- My Account
April 17th, 2007
Representatives from Merck will make a special presentation to researchers and scientists in universities and companies at the Nanotech 2007 conference on May 23, 2007 at the Santa Clara Convention Center in California.
Merck recently acquired Sirna Therapeutics, a leader in efforts to create RNAi-based therapeutics that could significantly alter the treatment of disease. RNAi-based therapeutics selectively catalyze the destruction of the RNA transcribed from an individual gene enabling an novel approach to discovering drugs with the potential to produce highly specific, potent, and long-lasting effects.
|Related News Press|
In-cell molecular sieve from protein crystal February 14th, 2017
Particle Works creates range of high performance quantum dots February 23rd, 2017
GLOBALFOUNDRIES Announces Availability of 45nm RF SOI to Advance 5G Mobile Communications: Optimized RF features deliver high-performance solutions for mmWave beam forming applications in 5G smartphones and base stations February 22nd, 2017
Particles from outer space are wreaking low-grade havoc on personal electronics February 19th, 2017
National Space Society's Space Settlement Summit Draws Industry Leaders February 4th, 2017